Rethinking Medicaid Coverage and Payment Policy to Promote High Value Care: The Case of Long-Acting Reversible Contraception
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Women's Health Issues
- Vol. 28 (2) , 137-143
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Affordable Care Act’s Mandate Eliminating Contraceptive Cost Sharing Influenced Choices Of Women With Employer CoverageHealth Affairs, 2016
- Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness — United States, 2011–2013 and 2015MMWR. Morbidity and Mortality Weekly Report, 2016
- Declines in Unintended Pregnancy in the United States, 2008–2011New England Journal of Medicine, 2016
- Global fee prohibits postpartum provision of the most effective reversible contraceptivesContraception, 2014
- Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs)Contraception, 2014
- Postpartum Contraception in Publicly-Funded Programs and Interpregnancy IntervalsObstetrics & Gynecology, 2013
- Factors Associated With Provision of Long-Acting Reversible Contraception Among Adolescent Health Care ProvidersJournal of Adolescent Health, 2013
- Desperately Seeking Savings: States Shift More Medicaid Enrollees To Managed CareHealth Affairs, 2011
- Family Planning as a Cost-Saving Preventive Health ServiceNew England Journal of Medicine, 2011
- Challenges in Translating Evidence to PracticeObstetrics & Gynecology, 2008